Notice of Change to add PA-20-195 in NOT-CA-21-121 "Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention"
Notice Number:
NOT-CA-22-114

Key Dates

Release Date:

August 3, 2022

Related Announcements

NOT-CA-21-121 - Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this notice is to amend NOT-CA-21-121 "Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention" with updates to the Related Announcements and Application and Submission Information.

Related Announcements

Currently reads:

PAR-19-133- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

PAR-19-134- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed

PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PA-20-188- NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

PAR-20-292- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

PAR-21-038- Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

PAR-21-300- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)

PAR-21-301- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)

Modified to read (in bold italics):

PAR-19-133- Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

PAR-19-134- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed

PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PA-20-188- NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

PAR-20-292- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

PAR-21-038- Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

PAR-21-300- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)

PAR-21-301- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)

PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Application and Submission Information

Currently reads:

This notice applies to due dates on or after February 5, 2022, and subsequent receipt dates through September 8, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

Activity Code

FOA Title

First Available Due Date

PAR-19-133

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

February 25, 2022

PAR-19-134

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed

February 25, 2022

PA-20-185

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

February 5, 2022

PA-20-188

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

February 12, 2022

PAR-20-292

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

February 22, 2022

PAR-21-038

Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

January 26, 2022

PAR-21-300

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)

February 12, 2022

PAR-21-301

NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)

February 12, 2022

Modified to read (in bold italics):

This notice applies to due dates on or after February 5, 2022, and subsequent receipt dates through September 8, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

Activity Code

FOA Title

First Available Due Date

PAR-19-133

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

February 25, 2022

PAR-19-134

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed

February 25, 2022

PA-20-185

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

February 5, 2022

PA-20-188

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

February 12, 2022

PAR-20-292

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

February 22, 2022

PAR-21-038

Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

January 26, 2022

PAR-21-300

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)

February 12, 2022

PAR-21-301

NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)

February 12, 2022

PA-20-195

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

October 16, 2022

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Phillip J. Daschner, MSc
National Cancer Institute (NCI)
Telephone: 240-276-6227
Email: pd93u@nih.gov

Sharon Ross, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-7124
Email: rosssha@mail.nih.gov

Amit Kumar, PhD
National Cancer Institute (NCI)
Telephone: 240-276-7617
Email: kumara@mail.nih.gov